Revance Therapeutics, Inc. (RVNC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC). https://mma.prnewswire.com/media/2395212/Glancy_Prongay.jpg IF YOU SUFFERED A LOSS ON YOUR REVANCE INVESTMENTS, CLICK HEREBEFORE MARCH 4, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT […]